COVID-19 : a pandemic experience that illuminates potential reforms to health research
© 2020 The Authors. Published under the terms of the CC BY 4.0 license..
COVID-19 has halted research around the globe and forced researchers out of their laboratories. Non-emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID-19. Yet, the inability to conduct research during COVID-19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
EMBO molecular medicine - 12(2020), 11 vom: 06. Nov., Seite e13278 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kozlowski, Hannah N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.12.2020 Date Revised 28.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.15252/emmm.202013278 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315668385 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315668385 | ||
| 003 | DE-627 | ||
| 005 | 20231225155422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15252/emmm.202013278 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315668385 | ||
| 035 | |a (NLM)32996267 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kozlowski, Hannah N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 |b a pandemic experience that illuminates potential reforms to health research |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2020 | ||
| 500 | |a Date Revised 28.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 The Authors. Published under the terms of the CC BY 4.0 license. | ||
| 520 | |a COVID-19 has halted research around the globe and forced researchers out of their laboratories. Non-emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID-19. Yet, the inability to conduct research during COVID-19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Farkouh, Michael E |e verfasserin |4 aut | |
| 700 | 1 | |a Irwin, Meredith S |e verfasserin |4 aut | |
| 700 | 1 | |a Radvanyi, Laszlo G |e verfasserin |4 aut | |
| 700 | 1 | |a Schimmer, Aaron D |e verfasserin |4 aut | |
| 700 | 1 | |a Tabori, Uri |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenblum, Norman D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EMBO molecular medicine |d 2009 |g 12(2020), 11 vom: 06. Nov., Seite e13278 |w (DE-627)NLM192618962 |x 1757-4684 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g number:11 |g day:06 |g month:11 |g pages:e13278 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.15252/emmm.202013278 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2020 |e 11 |b 06 |c 11 |h e13278 | ||